ArticleCells2026

Circulating miR-22 Early Predicts TACE Non-Response and Targets WEE1 in Hepatocellular Carcinoma.

Laura Gramantieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.